Synopsis
Synopsis
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gtpl7055
2. Q420394
3. [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol
| Molecular Weight | 1464.8 g/mol |
|---|---|
| Molecular Formula | C11H44Al8O51S8 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 51 |
| Rotatable Bond Count | 36 |
| Exact Mass | 1463.713824 g/mol |
| Monoisotopic Mass | 1463.713824 g/mol |
| Topological Polar Surface Area | 532 Ų |
| Heavy Atom Count | 78 |
| Formal Charge | 0 |
| Complexity | 2400 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 17 |
| 1 of 2 | |
|---|---|
| Drug Name | Carafate |
| PubMed Health | Sucralfate (By mouth) |
| Drug Classes | Antiulcer, Protectant |
| Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
| Active Ingredient | Sucralfate |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 1gm/10ml; 1gm |
| Market Status | Prescription |
| Company | Forest Labs |
| 2 of 2 | |
|---|---|
| Drug Name | Carafate |
| PubMed Health | Sucralfate (By mouth) |
| Drug Classes | Antiulcer, Protectant |
| Drug Label | CARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus... |
| Active Ingredient | Sucralfate |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 1gm/10ml; 1gm |
| Market Status | Prescription |
| Company | Forest Labs |
API SUPPLIERS
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-08-05
Pay. Date : 2024-07-03
DMF Number : 40145
Submission : 2024-07-04
Status : Active
Type : II
NDC Package Code : 54469-0010
Start Marketing Date : 2023-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-05
Pay. Date : 2015-12-18
DMF Number : 30056
Submission : 2016-02-03
Status : Active
Type : II
Certificate Number : R0-CEP 2019-185 - Rev 01
Issue Date : 2023-08-18
Type : Chemical
Substance Number : 1796
Status : Valid
NDC Package Code : 69984-001
Start Marketing Date : 2016-01-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2019-04-22
Registration Number : 20190211-211-J-310(2)
Manufacturer Name : Zhejiang Haisen Pharmaceutical Co., Ltd
Manufacturer Address : Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province, China.
GDUFA
DMF Review : Reviewed
Rev. Date : 2025-04-02
Pay. Date : 2025-01-22
DMF Number : 41032
Submission : 2024-12-25
Status : Active
Type : II
NDC Package Code : 31260-401
Start Marketing Date : 2025-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3542
Submission : 1979-06-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-18
Pay. Date : 2014-04-09
DMF Number : 16589
Submission : 2003-05-13
Status : Active
Type : II
NDC Package Code : 55512-0020
Start Marketing Date : 2014-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7552
Submission : 1988-06-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5825
Submission : 1985-05-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6048
Submission : 1985-09-27
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6108
Submission : 1985-10-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3542
Submission : 1979-06-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7282
Submission : 1988-01-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6048
Submission : 1985-09-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7160
Submission : 1987-09-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7552
Submission : 1988-06-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5825
Submission : 1985-05-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6331
Submission : 1985-10-25
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7186
Submission : 1987-11-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6057
Submission : 1985-09-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 1GM
USFDA APPLICATION NUMBER - 18333
DOSAGE - SUSPENSION;ORAL - 1GM/10ML
USFDA APPLICATION NUMBER - 19183
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Film Formers & Plasticizers
Granulation
Lubricants & Glidants
Coating Systems & Additives
Co-Processed Excipients
Taste Masking
Controlled & Modified Release
Parenteral
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Solubilizers
Emulsifying Agents
Topical
Rheology Modifiers
API Stability Enhancers
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
90
PharmaCompass offers a list of Sucralfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sucralfate manufacturer or Sucralfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sucralfate manufacturer or Sucralfate supplier.
PharmaCompass also assists you with knowing the Sucralfate API Price utilized in the formulation of products. Sucralfate API Price is not always fixed or binding as the Sucralfate Price is obtained through a variety of data sources. The Sucralfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antepsin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antepsin, including repackagers and relabelers. The FDA regulates Antepsin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antepsin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antepsin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antepsin supplier is an individual or a company that provides Antepsin active pharmaceutical ingredient (API) or Antepsin finished formulations upon request. The Antepsin suppliers may include Antepsin API manufacturers, exporters, distributors and traders.
click here to find a list of Antepsin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antepsin DMF (Drug Master File) is a document detailing the whole manufacturing process of Antepsin active pharmaceutical ingredient (API) in detail. Different forms of Antepsin DMFs exist exist since differing nations have different regulations, such as Antepsin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antepsin DMF submitted to regulatory agencies in the US is known as a USDMF. Antepsin USDMF includes data on Antepsin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antepsin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antepsin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Antepsin Drug Master File in Japan (Antepsin JDMF) empowers Antepsin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Antepsin JDMF during the approval evaluation for pharmaceutical products. At the time of Antepsin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Antepsin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Antepsin Drug Master File in Korea (Antepsin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Antepsin. The MFDS reviews the Antepsin KDMF as part of the drug registration process and uses the information provided in the Antepsin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Antepsin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Antepsin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Antepsin suppliers with KDMF on PharmaCompass.
A Antepsin CEP of the European Pharmacopoeia monograph is often referred to as a Antepsin Certificate of Suitability (COS). The purpose of a Antepsin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Antepsin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Antepsin to their clients by showing that a Antepsin CEP has been issued for it. The manufacturer submits a Antepsin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Antepsin CEP holder for the record. Additionally, the data presented in the Antepsin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Antepsin DMF.
A Antepsin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Antepsin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Antepsin suppliers with CEP (COS) on PharmaCompass.
A Antepsin written confirmation (Antepsin WC) is an official document issued by a regulatory agency to a Antepsin manufacturer, verifying that the manufacturing facility of a Antepsin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Antepsin APIs or Antepsin finished pharmaceutical products to another nation, regulatory agencies frequently require a Antepsin WC (written confirmation) as part of the regulatory process.
click here to find a list of Antepsin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antepsin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antepsin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antepsin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antepsin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antepsin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antepsin suppliers with NDC on PharmaCompass.
Antepsin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antepsin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antepsin GMP manufacturer or Antepsin GMP API supplier for your needs.
A Antepsin CoA (Certificate of Analysis) is a formal document that attests to Antepsin's compliance with Antepsin specifications and serves as a tool for batch-level quality control.
Antepsin CoA mostly includes findings from lab analyses of a specific batch. For each Antepsin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antepsin may be tested according to a variety of international standards, such as European Pharmacopoeia (Antepsin EP), Antepsin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antepsin USP).
